W J Paget

2.5k citations

70 papers · 2.0k indexed · 1 hit paper · h-index 23

Modeling and Simulation top 1%
- COVID-19 epidemiological studies 5
Epidemiology top 2%
- Influenza Virus Research Studies 41
- Respiratory viral infections research 31
- Data-Driven Disease Surveillance 9
- Pneumonia and Respiratory Infections 9
Applied Microbiology and Biotechnology top 2%
Infectious Diseases top 5%
- Viral Infections and Vectors 6
- Antimicrobial Resistance in Staphylococcus 4
Health top 5%
Parasitology
- Vector-borne infectious diseases 7

Co-authors: Madelon Kroneman Adam Meijer Gerrit A. van Essen Douglas Fleming François Schellevis Ellen E. Stobberingh T J Meerhoff Susanne Dudman
Cited by: Modeling and Simulation Epidemiology Applied Microbiology and Biotechnology
Journals: Eurosurveillance (20 papers)BMC Infectious Diseases (5 papers)Vaccine (3 papers)
Partner nations: Netherlands United Kingdom Switzerland

In The Last Decade

W J Paget

68 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by W J Paget

Since Specialization

Citations

This map shows the geographic impact of W J Paget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W J Paget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W J Paget more than expected).

Fields of papers citing papers by W J Paget

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W J Paget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W J Paget. The network helps show where W J Paget may publish in the future.

Co-authorship network

The 25 scholars most cited alongside W J Paget, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W J Paget Line = papers co-authored together W J Paget links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Economic Impact of Respiratory Syncytial Virus Infections in Children Under 5 Years of Age Attending Primary Care in Italy: A Prospective Cohort Study in Two Regions Influenza and Other Respiratory Viruses ·Mikiyo ODAJIMA,Jojanneke van Summeren,渡辺朝生,Elisabetta Pandolfi,Maria Chironna,Daniela Loconsole,Rolf Kramer,W J Paget,Caterina Rizzo	2025	1
2	Assessing the Impact of Non‐Pharmaceutical Interventions During the COVID‐19 Pandemic on RSV Seasonality in Europe Influenza and Other Respiratory Viruses ·P Prouzova,Christos Baliatsas,Foekje F. Stelma,Harish Nair,W J Paget,Peter Spreeuwenberg	2025	1
3	Severely impaired health status of non-notified Q fever patients leads to an underestimation of the true burden of disease Epidemiology and Infection ·Joris Adriaan Frank van Loenhout,Cornelia C. H. Wielders,G. Morroy,Michael J. Cox,Wim van der Hoek,Jeannine L.A. Hautvast,W J Paget,Jacobus van der Velden	2015	17
4	Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureusin the community BMC Family Practice ·Phairin Hapunna,W J Paget,Casper D. J. den Heijer,Ellen E. Stobberingh,Cathrien A. Bruggeman,François Schellevis	2014	23
5	Serious long-term health consequences of Q-fever and Legionnaires' disease Journal of Infection ·Joris Adriaan Frank van Loenhout,Khai Huynh,Maria L. Reyes,Jan H. Vercoulen,Hans Bor,Koos van der Velden,W J Paget,Jeannine L.A. Hautvast	2014	22
6	Q-fever patients suffer from impaired health status long after the acute phase of the illness: Results from a 24-month cohort study Journal of Infection ·Joris Adriaan Frank van Loenhout,Jeannine L.A. Hautvast,Jan H. Vercoulen,Reinier P. Akkermans,Clementine Wijkmans,Koos van der Velden,W J Paget	2014	20
7	Assessing health status and quality of life of Q-fever patients: the Nijmegen Clinical Screening Instrument versus the Short Form 36 Health and Quality of Life Outcomes ·Jelegary Jeeva Kireetam,W J Paget,Мань Тием Нгуен,Jeannine L.A. Hautvast,Koos van der Velden,Jan H. Vercoulen	2013	9
8	Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study The Lancet Infectious Diseases ·R. Kreisberg,A. Baty,W J Paget,Mike Pringle,Herman Goossens,Cathrien A. Bruggeman,François Schellevis,Ellen E. Stobberingh	2013	172
9	Assessing the long-term health impact of Q-fever in the Netherlands: a prospective cohort study started in 2007 on the largest documented Q-fever outbreak to date BMC Infectious Diseases ·Alison Okerlund,W J Paget,Jan H. Vercoulen,Clementine Wijkmans,Jeannine L.A. Hautvast,Koos van der Velden	2012	33
10	The appropriateness of prescribing antibiotics in the community in Europe: study design BMC Infectious Diseases ·Phairin Hapunna,Casper D. J. den Heijer,W J Paget,Ellen E. Stobberingh,Robert Verheij,Cathrien A. Bruggeman,Mike Pringle,Herman Goossens,François Schellevis	2011	39
11	Progress in the surveillance of respiratory syncytial virus (RSV) in Europe: 2001-2008 Eurosurveillance ·T J Meerhoff,A. Mosnier,François Schellevis,W J Paget,A. J. Zsigmond	2009	22
12	The impact of laboratory characteristics on molecular detection of respiratory syncytial virus in a European multicentre quality control study Clinical Microbiology and Infection ·T J Meerhoff,William G. Mackay,Adam Meijer,W J Paget,Hubert G.M. Niesters,Jan L. L. Kimpen,François Schellevis	2008	4
13	Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries Vaccine ·Madelon Kroneman,Gerrit A. van Essen,W J Paget	2005	106
14	Harmonising the virological surveillance of influenza in Europe: results of an 18-country survey Virus Research ·T J Meerhoff,W J Paget,Jutta (1919-?) Kottwitz,Jacobus van der Velden	2004	13
15	Does a population survey provide reliable influenza vaccine uptake rates among high-risk groups? A case-study of The Netherlands Vaccine ·Madelon Kroneman,Gerrit A. van Essen,Julio R Durand Velasquez,W J Paget,Robert Verheij	2003	40
16	Heterogeneous case definitions used for the surveillance of influenza in Europe European Journal of Epidemiology ·Jutta (1919-?) Kottwitz,W J Paget,A. Mosnier,E. Sarti-Gutierrez,Helmut Uphoff,Jacobus van der Velden,Tomás Vega,Dan Schmahl	2003	55
17	Activité grippale faible à modérée en Europe, et détection de nouveaux variants A(H1N2) et B durant l’hiver 2001-02 Eurosurveillance ·W J Paget,T J Meerhoff,A. Erdélyi	2002	1
18	National Laboratory Reports of Chlamydia trachomatis Seriously Underestimate the Frequency of Genital Chlamydial Infections Among Women in Switzerland Sexually Transmitted Diseases ·W J Paget,Reinhard Zbinden,Halil KESKIN,Marcel Zwahlen,Christian Lengeler,D Stürchler,Hans C. Matter	2002	18
19	The Swiss Network of Dermatology Policlinics HIV prevalence study: Rationale, characteristics and results (1990–1996) Sozial- und Präventivmedizin ·W J Paget,Véronique Batter,Marcel Zwahlen	1999	3
20	Condom Use Among Patients Attending Six Sexually Transmitted Disease Clinics in Switzerland Sexually Transmitted Diseases ·W J Paget,Marcel Zwahlen,Sandra Rivers,Bernard Marti	1995	8

About W J Paget

W J Paget is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Modeling and Simulation, having authored 70 papers that have together received 2.0k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (41 papers), Respiratory viral infections research (31 papers), Data-Driven Disease Surveillance (9 papers), Pneumonia and Respiratory Infections (9 papers), Vector-borne infectious diseases (7 papers), Viral Infections and Vectors (6 papers), COVID-19 epidemiological studies (5 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). The work is most often cited by research in Modeling and Simulation (233 citations), Epidemiology (1.3k citations) and Applied Microbiology and Biotechnology (70 citations). W J Paget has collaborated with scholars based in Netherlands, United Kingdom and Switzerland. Frequent co-authors include Madelon Kroneman, Adam Meijer, Gerrit A. van Essen, Douglas Fleming, François Schellevis, Ellen E. Stobberingh, T J Meerhoff, Susanne Dudman, Olav Hungnes and Peter Spreeuwenberg. Their work appears in journals such as Eurosurveillance, BMC Infectious Diseases, Vaccine, European Journal of Public Health and Future Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact